YAP1 and pulmonary arterial hypertension: To address these questions, we examined the role of PASMC-specific Sphk1 in vivo and in vitro, as well as the potential role of SPHK1-dependent YAP1 signaling in the development of pulmonary vascular remodeling and PAH.